Renalytix Plc (AIM:RENX)
5.35
-0.10 (-1.76%)
Oct 16, 2026, 1:09 PM GMT
Renalytix Market Cap
Renalytix has a market cap or net worth of 32.91 million as of October 16, 2026. It is the 31,378th most valuable company in the world and the 689th biggest in the United Kingdom. Its market cap has decreased by 7.22% in one year.
Market Cap
32.91M
Enterprise Value
32.61M
Revenue
2.45M
Global Rank
Country Rank
#689 United Kingdom
PE Ratio
n/a
ChartMarket Cap Chart
Since November 6, 2018, Renalytix's market cap has decreased from 64.58M to 32.91M, a decrease of -49.04%. That is a compound annual growth rate of -8.13%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 16, 2026 | 32.91M | 27.63% |
| Dec 31, 2025 | 25.78M | -27.58% |
| Dec 31, 2024 | 35.60M | 129.87% |
| Dec 29, 2023 | 15.49M | -71.47% |
| Dec 30, 2022 | 54.30M | -87.89% |
| Dec 31, 2021 | 448.32M | 27.67% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Nov 6, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Craneware | 371.97M |
| Optima Health | 263.78M |
| Diaceutics | 171.89M |
| MedPal AI | 42.30M |
| Cambridge Cognition Holdings | 13.04M |
| Feedback | 2.82M |
| Imaging Biometrics | 2.16M |
| Trellus Health | 172.05K |